Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation Academic Article uri icon

  • Overview
  • Identity
  • Additional Document Info
  • View All


  • AbstractPeople with opioid use disorders are overrepresented in correctional facilities, and are at high risk of opioid overdose. Despite the fact that buprenorphine/naloxone is the first line treatment for people with opioid use disorder, there are often institutional, clinical, and logistical barriers to buprenorphine/naloxone initiation in correctional facilities. Guided by the knowledge-to-action framework, this knowledge translation project focused on synthesizing knowledge and developing a tool for buprenorphine/naloxone initiation that was tailored to correctional facilities, including jails. This information and tool can be used to support buprenorphine/naloxone access for people in correctional facilities, in parallel with other efforts to address barriers to treatment initiation in correctional facilities.


  • Regenstreif, Lori
  • Sadik, Marina
  • Beaulieu, Erin
  • Bodkin, Claire
  • Kiefer, Lori
  • Guenter, Dale
  • Lee, Patsy WP
  • Kouyoumdjian, Fiona

publication date

  • December 2022